Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit (26S) ribosomal DNA gene.

National Center for Agricultural Utilization Research, United States Department of Agriculture, Peoria, Illinois 61604, USA.
Journal of Clinical Microbiology (Impact Factor: 4.23). 06/1997; 35(5):1216-23.
Source: PubMed

ABSTRACT Clinically important species of Candida and related organisms were compared for extent of nucleotide divergence in the 5' end of the large-subunit (26S) ribosomal DNA (rDNA) gene. This rDNA region is sufficiently variable to allow reliable separation of all known clinically significant yeast species. Of the 204 described species examined, 21 appeared to be synonyms of previously described organisms. Phylogenetic relationships among the species are presented.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Candida pericarditis is a rare clinical entity with a high fatality, primarily attributed to difficulty in diagnosis. Unfortunately, the diagnosis is made post‐mortem in more than 50% of cases, and thus a high index of clinical suspicion is crucial. Case presentation: We report a rare case of fungal pericardial effusion caused by the recently recognized multidrug‐resistant Candida auris, which was cultured from pericardial fluid, blood, bronchoalveolar lavage and urine of a chronic liver disease patient while on empiric fluconazole therapy. The yeast was misidentified as Candida haemulonii by the VITEK2 commercial identification system, and was confirmed as C. auris by internal transcribed spacer and large ribosomal subunit sequencing. In addition, the VITEK2 AST card erroneously revealed a high amphotericin B MIC (16 µg ml−1) and low caspofungin MIC (0.25 µg ml−1) that did not correlate with results from the reference Clinical and Laboratory Standards Institute (CLSI) microbroth dilution method. Based on VITEK2 MIC data, the patient was administered caspofungin. However, in vitro antifungal susceptibility data for C. auris by the CLSI method exhibited high MICs to fluconazole (64 µg ml−1) and caspofungin MIC (1 µg ml−1) but low MICs to amphotericin B (MIC range, 0.125−0.5 µg ml−1). The patient’s repeat pericardial fluid culture, despite caspofungin therapy for 12 days, grew C. auris and he died on day 13 of therapy. Conclusion: C. auris is a recently reported agent of fungaemia and deep‐seated infections and is notable for its antifungal resistance. Although early species identification and rapid antifungal susceptibility testing are needed in cases of critical infections, the reporting of rare yeast isolates exhibiting high MICs to antifungals by automated systems needs a cautionary approach.
    10/2014; 1(3):1-5. DOI:10.1099/jmmcr.0.003707
  • Source
    American Journal of Enology and Viticulture 05/2014; 66(2). DOI:10.5344/ajev.2014.14071 · 1.63 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We studied the epiphytic yeast species of the plants of the Negev Desert and the Dead Sea region, Israel, which are considered one of the most extreme hyper-arid lands in the world. For this purpose, we developed isolation protocols; we performed morphological, cultural and molecular identification tests, and compared yeast diversity between the locations and the plants. The composition of the yeast populations present in the study's plants underwent seasonal fluctuations, whereas differences in community compositions were significant within sites. The maximum number of species of yeast occurred in autumn and Cryptococcus spp. were predominant year round. The isolated yeast strains showed an unusual tolerance to extreme growth conditions, such as high temperatures (up to 72% viability at 50 °C), lethal hydrogen peroxide (H2O2), and NaCl concentrations. These results suggest that the epiphytic yeasts that inhabit the plants of the Dead Sea region and the Negev Desert have a community structure that is unique to the plant species and have a high tolerance to the harsh conditions that enables them to adapt to a hyper-arid ecosystem.
    Environmental Microbiology Reports 03/2014; 6(4). DOI:10.1111/1758-2229.12161 · 3.26 Impact Factor


Available from